These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12176886)

  • 1. Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques.
    Nathwani AC; Davidoff AM; Hanawa H; Hu Y; Hoffer FA; Nikanorov A; Slaughter C; Ng CY; Zhou J; Lozier JN; Mandrell TD; Vanin EF; Nienhuis AW
    Blood; 2002 Sep; 100(5):1662-9. PubMed ID: 12176886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
    Nathwani AC; Davidoff A; Hanawa H; Zhou JF; Vanin EF; Nienhuis AW
    Blood; 2001 Mar; 97(5):1258-65. PubMed ID: 11222368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector-mediated intrauterine gene transfer in early-gestation fetal macaques.
    Chan JKY; Gil-Farina I; Johana N; Rosales C; Tan YW; Ceiler J; Mcintosh J; Ogden B; Waddington SN; Schmidt M; Biswas A; Choolani M; Nathwani AC; Mattar CNZ
    FASEB J; 2019 Mar; 33(3):3954-3967. PubMed ID: 30517034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver.
    Nathwani AC; Gray JT; Ng CY; Zhou J; Spence Y; Waddington SN; Tuddenham EG; Kemball-Cook G; McIntosh J; Boon-Spijker M; Mertens K; Davidoff AM
    Blood; 2006 Apr; 107(7):2653-61. PubMed ID: 16322469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality control of recombinant adeno-associated virus type 2/human blood coagulation factor IX].
    Gao K; Wang JZ; Rao CM; Wu XB
    Yao Xue Xue Bao; 2003 Sep; 38(9):684-9. PubMed ID: 14730919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques.
    Mattar CN; Nathwani AC; Waddington SN; Dighe N; Kaeppel C; Nowrouzi A; Mcintosh J; Johana NB; Ogden B; Fisk NM; Davidoff AM; David A; Peebles D; Valentine MB; Appelt JU; von Kalle C; Schmidt M; Biswas A; Choolani M; Chan JK
    Mol Ther; 2011 Nov; 19(11):1950-60. PubMed ID: 21629224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model.
    Mattar CNZ; Gil-Farina I; Rosales C; Johana N; Tan YYW; McIntosh J; Kaeppel C; Waddington SN; Biswas A; Choolani M; Schmidt M; Nathwani AC; Chan JKY
    Mol Ther; 2017 Aug; 25(8):1843-1853. PubMed ID: 28462816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates.
    Salas D; Kwikkers KL; Zabaleta N; Bazo A; Petry H; van Deventer SJ; Aseguinolaza GG; Ferreira V
    Blood Adv; 2019 Sep; 3(17):2632-2641. PubMed ID: 31501158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaques.
    Brunetti-Pierri N; Liou A; Patel P; Palmer D; Grove N; Finegold M; Piccolo P; Donnachie E; Rice K; Beaudet A; Mullins C; Ng P
    Mol Ther; 2012 Oct; 20(10):1863-70. PubMed ID: 22828499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero.
    Schneider H; Mühle C; Douar AM; Waddington S; Jiang QJ; von der Mark K; Coutelle C; Rascher W
    J Gene Med; 2002; 4(1):46-53. PubMed ID: 11828387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent expression of canine factor IX in hemophilia B canines.
    Chao H; Samulski R; Bellinger D; Monahan P; Nichols T; Walsh C
    Gene Ther; 1999 Oct; 6(10):1695-704. PubMed ID: 10516718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of recombinant adeno-associated virus-mediated gene transfer.
    Malik AK; Monahan PE; Allen DL; Chen BG; Samulski RJ; Kurachi K
    J Virol; 2000 Apr; 74(8):3555-65. PubMed ID: 10729130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep.
    David AL; McIntosh J; Peebles DM; Cook T; Waddington S; Weisz B; Wigley V; Abi-Nader K; Boyd M; Davidoff AM; Nathwani AC
    Hum Gene Ther; 2011 Apr; 22(4):419-26. PubMed ID: 20919876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Adeno-Associated Viral Vectors Expressing Human Coagulation FIX-E456H Variant in Hemophilia B Mice.
    Le Quellec S; Dane AP; Barbon E; Bordet JC; Mingozzi F; Dargaud Y; Marais T; Biferi MG; Négrier C; Nathawani AC; Enjolras N
    Thromb Haemost; 2019 Dec; 119(12):1956-1967. PubMed ID: 31659733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero.
    Chen XG; Zhu HZ; Gong JL; Li F; Xue JL
    Acta Pharmacol Sin; 2004 Jun; 25(6):789-93. PubMed ID: 15169633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for hemophilia B mice with scAAV8-LP1-hFIX.
    Lu W; Zhou Q; Yang H; Wang H; Gu Y; Shen Q; Xue J; Dong X; Chen J
    Front Med; 2016 Jun; 10(2):212-8. PubMed ID: 27052253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of antigen expression with epigenetic modifications after rAAV delivery of a human factor IX variant in mice and rhesus macaques.
    Pekrun K; Stephens CJ; Gonzalez-Sandoval A; Goswami A; Zhang F; Tarantal AF; Blouse G; Kay MA
    Mol Ther; 2024 Jul; 32(7):2064-2079. PubMed ID: 38715361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy.
    Grimm D; Zhou S; Nakai H; Thomas CE; Storm TA; Fuess S; Matsushita T; Allen J; Surosky R; Lochrie M; Meuse L; McClelland A; Colosi P; Kay MA
    Blood; 2003 Oct; 102(7):2412-9. PubMed ID: 12791653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
    Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
    Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.
    Miao CH; Thompson AR; Loeb K; Ye X
    Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.